Emyria

D4, 661 Newcastle Street
Leederville WA 6007

Home

Contact Us

Updates

Annual Reports

Corporate Governance

Investor Research

Share Price

Announcements

New investors

Why Invest in Emyria?

Loyalty Option Offer

Presentations

Successes

Meet the Team

About Emyria

Webinars

Montserrat

Emyria Limited

upload.jpg

Emyria (ASX:EMD) has today announced that Medibank will fund screened and eligible customers to access Emyria’s Empax Clinic programs for Treatment-Resistant Depression (TRD) and Post-Traumatic Stress Disorder (PTSD) when admitted to Avive Health’s Brisbane licensed hospital.

This partnership marks the first expansion of Emyria’s insurer-funded services beyond Western Australia, establishing an Empax clinic on Australia’s East Coast and advancing the Company’s national growth strategy. By combining insurer support with hospital-based, psychiatrist-led care, Emyria continues to build a scalable framework for accessible, evidence-based mental health treatment.

Emyria Executive Chair, Greg Hutchinson, said:

“We’re pleased to extend our agreement with Medibank and bring our insurer funded Empax programs to Queensland. This represents an important step forward for patients, clinicians, and the broader health system.

“Our goal has always been to make world-class, evidence-based mental health care accessible to every Australian who needs it. By integrating insurer funding into high-quality hospital programs, we’re significantly reducing financial barriers that have historically limited access to comprehensive trauma and mood disorder treatments.

“With funded programs now operating across two states, Emyria is demonstrating that our data-driven model of care can scale nationally. This expansion will enable more Australians to access effective treatment for complex mental health conditions while contributing valuable data to help modernise and strengthen Australia’s healthcare system.”

Medibank Expands Funding to Support Eligible Patients at Emyria’s Brisbane Clinic